What is Annonacin and What Are its Effects?

Annonacin is a naturally occurring compound found in the fruit, seeds, and leaves of tropical trees in the Annonaceae family, most famously soursop (also called graviola or guanábana). It belongs to a larger class of molecules called acetogenins, and it has drawn scientific attention for two starkly different reasons: it kills certain cancer cells in the lab, and it appears to be toxic to brain cells in ways that resemble neurodegenerative disease. That dual identity makes annonacin one of the more complicated substances in plant biochemistry, and the research around it is still evolving in ways that matter for anyone who drinks soursop juice or takes graviola supplements.

Where Annonacin Comes From

Annonacin is produced by plants in the Annonaceae family, a large group of tropical and subtropical trees and shrubs. The most widely consumed of these is Annona muricata, known as soursop in English-speaking countries and by dozens of regional names worldwide. Soursop fruit is used to make juices, ice creams, candies, and shakes across Latin America, the Caribbean, Southeast Asia, and parts of Africa.¹ Beyond food, various parts of the plant have a long history of use in folk medicine for ailments ranging from fever to parasitic infections.²

But soursop is not the only source. Annonacin has been isolated from the seeds of cherimoya (Annona cherimolia), a closely related fruit popular in South America and parts of Southern Europe.³ It also shows up in pawpaw (Asimina triloba), the largest edible fruit native to North America. Measurements of pawpaw fruit pulp found an average annonacin concentration of about 0.07 mg per gram of pulp.⁴ A separate analysis using a different extraction method on lyophilized (freeze-dried) pawpaw pulp reported a considerably higher figure of about 7.7 mg per gram, though this number reflects a concentrated, dried sample rather than fresh fruit.⁵ Either way, the point is that annonacin is not confined to a single exotic fruit. Anyone eating soursop, cherimoya, or pawpaw is ingesting at least some of it.

How It Works Inside Cells

Annonacin belongs to a class of compounds called annonaceous acetogenins. These are fatty-acid-derived molecules with a distinctive ring structure in their middle and a lactone group at one end. Structurally, they are unusual enough to have attracted interest from medicinal chemists looking for new drug templates. But the biological property that defines annonacin is its ability to shut down a specific part of the cell’s energy-production machinery: mitochondrial complex I.

Mitochondria generate most of a cell’s energy by passing electrons along a chain of protein complexes. Complex I is the first and largest of these complexes, and when it gets blocked, the whole chain stalls. The cell’s supply of ATP, its main energy currency, drops. Annonacin is a potent inhibitor of this step.⁶ In lab experiments on cultured rat brain neurons, treatment with annonacin for 48 hours produced a concentration-dependent drop in ATP levels, followed by cell death.⁷

What makes annonacin especially worrisome for the brain is that it is lipophilic, meaning it dissolves easily in fats. The brain is a lipid-rich organ, and a fat-soluble toxin can accumulate there more readily than a water-soluble one. Researchers have developed methods to measure annonacin levels in rat brains after both intravenous and oral dosing, confirming that it does cross from the bloodstream into brain tissue.⁸

The Neurotoxicity Problem

The connection between annonacin and brain damage emerged from an epidemiological puzzle on the Caribbean island of Guadeloupe. In the late 1990s and early 2000s, neurologists noticed an unusually high rate of an atypical form of parkinsonism among the island’s population. Unlike ordinary Parkinson’s disease, this condition did not respond to levodopa, the standard treatment. It resembled progressive supranuclear palsy (PSP), a rarer and more aggressive neurodegenerative disease.⁹

When researchers investigated what set Guadeloupe apart, a pattern emerged: patients with this atypical parkinsonism consumed significantly more soursop fruit and herbal teas made from Annonaceae plants than healthy controls or patients with typical Parkinson’s disease.¹⁰ Soursop is deeply integrated into Guadeloupean cuisine and folk medicine, and some individuals consumed it daily over years or decades. This epidemiological link pointed to annonacin as a probable cause, since experimental studies in cell cultures had already shown that annonacin, as a complex I inhibitor present in soursop, could damage the types of neurons that degenerate in parkinsonism.¹¹

Laboratory studies have fleshed out the details. In cell cultures of midbrain dopaminergic neurons — the type of brain cell that dies in Parkinson’s disease — annonacin turned out to be remarkably potent. It killed these neurons at concentrations roughly a hundred times lower than MPP+, the toxic metabolite of the synthetic neurotoxin MPTP that is sometimes used to model Parkinson’s in the lab.¹² In live rats given annonacin through chronic infusion, brain cell counts revealed significant losses: roughly a third of dopaminergic neurons in one key brain region (the substantia nigra) and close to 40% of certain neurons in the striatum, accompanied by a large inflammatory response.¹³

Tau Protein and Connections to Dementia

Beyond killing dopaminergic neurons, annonacin causes something else that caught researchers’ attention: it disrupts the behavior of tau, a protein that normally helps stabilize the internal scaffolding of nerve cells. In cultured neurons exposed to annonacin, tau migrated abnormally from the axons (the long extensions of the cell) back toward the cell body. This redistribution is a hallmark of tauopathies, a group of neurodegenerative conditions that includes PSP, frontotemporal dementia, and Alzheimer’s disease. The researchers traced this effect directly to the energy crisis caused by complex I inhibition. When they restored the cell’s ability to produce ATP through an alternative route, the tau redistribution was prevented, as was cell death. Antioxidants alone, which mopped up the reactive oxygen species that complex I blockade also generates, did not help.⁷

This finding was extended to genetically modified mice carrying a mutation (R406W) associated with a hereditary form of frontotemporal dementia. When these mice were exposed to annonacin, they showed a synergistic effect: tau became abnormally phosphorylated and accumulated in neuron cell bodies more than in either the genetic mutation alone or annonacin exposure alone. The combination also impaired the cell’s ability to break down and recycle damaged proteins through its normal disposal system. In mice without the tau mutation, the same dose of annonacin caused far less damage, suggesting that genetic predisposition could make certain individuals more vulnerable to the neurotoxic effects of dietary annonacin.¹⁴

Anticancer Research in the Lab

The same property that makes annonacin dangerous to neurons — its ability to starve cells of energy — has made it a subject of cancer research. Rapidly dividing cancer cells have high energy demands, and shutting down their mitochondria can trigger cell death. In lab experiments, annonacin has shown cytotoxic effects against several types of cancer cells.

In endometrial cancer cell lines, annonacin stopped cell division and triggered programmed cell death (apoptosis) at moderate concentrations. After 72 hours of treatment, roughly two-thirds of the cancer cells were dead, with evidence of the molecular markers that indicate an orderly self-destruction process rather than random cell damage.¹⁵ In triple-negative breast cancer cells — an aggressive subtype with few treatment options — annonacin showed selective toxicity, killing cancer cells while being about 2.6 times less toxic to normal cells. At lower concentrations it also appeared to stimulate immune-related signaling, though this shifted to suppression at higher doses.¹⁶

Perhaps the most striking selectivity was seen with prostate cancer cells. Annonacin was potently toxic to an aggressive prostate carcinoma line while causing no harm to normal prostate cells at the same concentrations, a contrast to the chemotherapy drug docetaxel, which killed both indiscriminately. Interestingly, the mechanism of cell death in this case did not appear to be standard apoptosis, suggesting annonacin may kill different cancer types through different pathways.¹⁷

A critical caveat: all of these results come from cell cultures and animal models, not from human clinical trials. Killing cancer cells in a dish is a far cry from treating cancer in a person, and many compounds that look promising in vitro fail when they encounter the complexity of a living human body. There are currently no approved cancer therapies based on annonacin, and the neurotoxicity concerns described above make it a particularly tricky candidate to develop into a drug. Eating soursop as a cancer treatment, which some alternative medicine websites promote, is not supported by clinical evidence.

Dietary Exposure and Supplement Risks

For most people, the practical question is whether eating soursop fruit or drinking its juice poses a real neurological risk. The honest answer is that nobody knows the precise safe threshold. The Guadeloupe data show a clear association between heavy, long-term soursop consumption and atypical parkinsonism, but those cases involved people who consumed soursop products regularly over years. Occasional consumption almost certainly carries less risk, but no study has defined exactly where the line falls.

The supplement market adds another layer of concern. Graviola leaf capsules and extracts are sold widely as dietary supplements, often promoted for immune support or cancer prevention. An analysis of seven commercially available Annona muricata leaf products found enormous variation in annonacin content, ranging from about 1 to 3 mg per gram of product. When accounting for the recommended daily dose printed on each label, the total daily annonacin intake ranged from about 0.8 mg to nearly 6.5 mg, a roughly eightfold spread.¹⁸ Someone taking one of these supplements has essentially no way of knowing how much annonacin they are actually ingesting, and the products are not standardized for this compound. The researchers behind that analysis concluded that much better quality control is needed, particularly for products marketed to cancer patients who may take them daily for extended periods.

Soursop juice is popular in Puerto Rico, Mexico, Brazil, Malaysia, India, and many other countries, and millions of people drink it without developing neurological disease. The question of individual vulnerability likely matters a great deal here. The mouse studies described earlier showed that a genetic predisposition to tau dysfunction amplified annonacin’s neurotoxic effects dramatically. It is plausible that some people carry genetic variants that make them more susceptible to cumulative annonacin exposure, while others can handle moderate amounts without noticeable harm. This is an area where the science is genuinely incomplete.

Research Into Protective Countermeasures

Given the neurotoxic potential of annonacin and the reality that millions of people consume Annonaceae products, researchers have begun looking for compounds that might protect brain cells from the damage. One recent study tested several activators of the Nrf2 pathway, a cellular defense system that ramps up the production of protective proteins when cells are under stress. In human dopaminergic neuron cultures treated with annonacin, most of the Nrf2-activating compounds improved cell survival, reduced oxidative damage, and decreased the abnormal tau phosphorylation that annonacin triggers. One compound in particular, a p62 activator, was especially effective at reducing neurite degeneration. Surprisingly, ezetimibe — a drug already approved for lowering cholesterol — appeared to prevent the overproduction of a particularly harmful form of tau (4R-tau) that annonacin induces.¹⁹

These findings are preliminary and cell-culture-based, so they cannot be translated into medical advice yet. But they illustrate an interesting direction: rather than simply warning people away from soursop, some researchers are trying to understand whether existing drugs could offer protection against chronic low-level exposure. If a commonly used medication like ezetimibe turns out to blunt annonacin’s worst neurological effects in animal models or human studies, it would change the risk calculus for populations where Annonaceae consumption is culturally important.

How Scientists Measure Annonacin

Part of the difficulty in assessing real-world risk is that measuring annonacin in food, supplements, and biological samples is technically challenging. The compound does not have a simple colorimetric test; it requires sophisticated analytical chemistry. Researchers have developed methods using ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) to detect and quantify annonacin in both rat blood plasma and brain tissue.²⁰ Similar high-resolution mass spectrometry methods have been applied to food products like pawpaw fruit, where the analysis also revealed several previously unquantified isomers of annonacin alongside the main compound.⁵

The existence of these isomers is worth flagging. Annonacin is the best-studied acetogenin, but it is not the only one present in the fruit. Other compounds in the same chemical family, such as squamocin, are also found in the same plants and likely have overlapping biological effects. Most toxicity research has focused on annonacin specifically, which means the total risk from eating a whole fruit could be somewhat higher than what annonacin alone would predict. This is another gap in the current understanding that makes definitive safety statements difficult.

The Pawpaw Angle

Soursop gets most of the attention in discussions of annonacin, but pawpaw deserves a mention of its own. Asimina triloba grows wild across much of the eastern United States, and interest in the fruit has surged in recent years among foragers, farmers’ market shoppers, and craft beverage makers. Pawpaw has a custard-like texture and a flavor often compared to banana and mango, and it has developed something of a cult following.

The finding that pawpaw fruit pulp contains measurable annonacin was published specifically to flag a potential neurotoxicity concern.⁴ Pawpaw is consumed in much smaller quantities than soursop in most of the world, and seasonal availability limits intake to a few weeks per year for most foragers. Still, anyone eating pawpaw regularly, or making large batches of pawpaw pulp to freeze for year-round use, is getting a dose of the same compound that has been linked to neurodegeneration in heavy soursop consumers. Whether the concentrations and typical consumption patterns are enough to matter is genuinely unknown. The research has not been done in pawpaw-eating populations the way it has in Guadeloupe for soursop.